It tells you in the alerts a few names but doesn’t give a list anymore. You can check it often to know who is liking it but that’s too much to monitor.
The algorithms work different. Followers don’t matter much on TikTok for example. The data is a 🍌🍍🍊🍏🥭🥝 fruit salad lol
We just count pills anyways. Not real patient care. 🫠
Copy/paste lol
Because all of my posts are on both Bluesky and X it’s really easy to compare how they’re doing in terms of engagement…. Bluesky sucks and it makes me really sad to say that. It’s so bad that I question whether it’s even worth posting anything here. I’m hoping the future will be brighter here.
I make the post for TikTok and then use that video for Instagram which cross posts to Facebook. from there, I posted onto X and then onto Bluesky. So I really only have to do one video to post it onto five different platforms. It is time-consuming though.
I did shoot a message over to the author of the tweet, but no response just yet. I also want to know more. I suppose an email over to the man himself. David Patterson might be the way to go.
The fact that I cannot tell you a direct answer makes me feel not great even though I know many people are legit there, I couldn’t tell you a percent. I feel like that really tracks for the whole vibe of X right now.
This is a fact 💯
I don’t expect people to start going back to the platform formally known as Twitter. But folks do still check in there a lot more I think because it was so established.
Seems like a fact that people just haven’t migrated over to the butterfly like we wish they had. I use X but sparingly now.
I also find the X experience pretty horrible. I go to specific profiles and otherwise don’t spend time there. I keep a presence to have some kind of voice but don’t put much energy into it.
❤️❤️❤️❤️❤️❤️❤️❤️❤️❤️
IG beats all but is not a good set up for science discussions.
I entirely can’t see who likes posts in X but look at this example. 1 repost, 6 likes, 2 save on 🦋. 24 likes, 6 repost, 5 saves on ❌. Is a consistent pattern. I have way more followers on X so maybe that has to do with it but still the effort seems to be more fruitful over there.
Screening patients for colonisation of drug resistant organisms can help reduce carbapenem use and duration of antibiotics in febrile neutropenia
#escmidglobal2026
Whoa… how to learn more about this? Any idea?
David Paterson at #ESCMIDGlobal2026 Highlights important issue of generic versus brand name meropenem – previous work has suggested chemical differences, harder to dissolve and even higher mortality with generic preparations
Dr Neil Stone talking at a podium showing slides
Listening to @drneilstone.bsky.social talk about Twitter vs Bluesky in Arena 3:
Says don’t concede space in Twitter to anti-science influencers
#ESCMIDGlobal2026
#IDSky #clinmicro
📊 Looking at Bluesky and X, the science community is still stronger on X from what I’m seeing with #ESCMIDglobal2026 content
cc: @absteward.bsky.social @krutikamh.bsky.social @drneilstone.bsky.social
“The Year in Clinical Micro” at #ESCMIDGlobal2026 🔬
A devastating reality:
⚠️ >3 million children died from AMR-related infections in 2022
🌍 Highest burden in Southeast Asia & Africa
💊 Many deaths linked to Watch & Reserve antibiotics
AMR is already a leading cause of child mortality.
Normal urine is not sterile!
Urine microbiome being introduced by @nicoledenisco.bsky.social
#ESCMIDGlobal2026 #UTISky
🔥Late Breakers
PeterPen RCT prelim results challenges carbapenem default in ESBL BSI
Pip/tazo vs MER (EI)
✅Non-inferior 7d failure(29.4% vs 33.5%)
❌No early mortality signal
30d mortality 14.4%(interim)
👉Will mortality follow?MERINO taught us the hard way!
#ESCMIDGlobal2026 #IDsky
Erin McCreary at the podium with a slide showing her and Ryan Shields recording the first Breakpoints episode
Now @erinmccreary.bsky.social is speaking to a packed house on podcasting in infectious diseases, with photo of her and Ryan Shields recording the first #Breakpoints podcast in 2018 @sidpharm.bsky.social
#ESCMIDGlobal2026
Smiling selfie 1
Smiling selfie 2
Despite its worldwide prevalence, research about #UTI is sparse here at #ESCMIDGlobal2026. But managed to find a concentrated mini-population of researchers at the poster session niche—enriched for the London strain, but quite a small sample size, p values not reaching significance! #UTISky #IDSky
Thank you for commenting. I appreciate you!
💊Antibiotic shortages - they are a problem! Here is a fantastic poster from #ESCMIdglobal2026 that discusses the issue!
cc @escmid.bsky.social @krutikakuppalli.bsky.social @absteward.bsky.social @drneilstone.bsky.social
🤔🤔 Daptomycin - are premixed bags the way to go when doses vary by weight, organism, and infection type? #ESCMIDglobal2026 trying these new videos with posters as a social media ambassador for the Congress. Any feedback or suggestions are always appreciated!
cc @escmid.bsky.social
💻👾Antibiotic stewardship tools are super important. How are they being kept alive? Who keeps them alive and who owns them? #ESCMIDglobal2026 #pharmacist #Antibiotics
cc: @escmid.bsky.social @absteward.bsky.social @dianeashiru.bsky.social @krutikakuppalli.bsky.social @drneilstone.bsky.social
🦷 💊 Dental prescribing and antibiotic stewardship - here is a great poster from Dr. Goff at #ESCMIDglobal2026 #pharmacist #dentist #Antibiotics @escmid.bsky.social @krutikakuppalli.bsky.social @drneilstone.bsky.social
A post applicable way beyond just #ESCMIDGlobal2026! 👇
#MedSky #AcademicSky
Nice to put a face to a black and white circle today! 😆
